Keywords and phrases: counting process, polynomial estimation, Nelson-Aalen estimator, multiplicative intensity model, smoothing parameter.
Received: March 18, 2021; Accepted: May 17, 2021; Published: June 2, 2021
How to cite this article: Ratheesan K. and Anilkumar P., Smoothing intensities of counting process by using polynomial, JP Journal of Biostatistics 18(2) (2021), 209-230. DOI: 10.17654/JB018020209
This Open Access Article is Licensed under Creative Commons Attribution 4.0 International License
Reference:
[1] O. Aalen, Nonparametric inference for a family of counting processes, The Annals of Statistics 6(4) (1978), 701-726. [2] Jiyoung Ahn, Rashmi Sinha et al., Human gut microbiome and risk for colorectal cancer, Journal of the National Cancer Institute 105 (2013), 1907-1911. [3] P. Anilkumar, K. K. Hamsa and K. Ratheesan, Density estimation using polynomial for complete and right censored samples, Far East Journal of Theoretical Statistics 55(1) (2019), 1-21. [4] Z. Cai, Kernel density and hazard rate estimation for censored dependent data, Journal of Multivariate Analysis 67(1) (1998), 23-34. [5] C. G. Moertel, T. R. Fleming et al., Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma, New England J. Medicine 322 (1990), 352-358. [6] C. G. Moertel, T. R. Fleming et al., Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage II colon carcinoma: a final report, Ann. Intern. Med. 122 (1995), 321-326. [7] Feng Chen, Richard M. Huggins et al., Nonparametric estimation of multiplicative counting process intensity functions with an application to the Beijing SARS epidemic, Communications in Statistics - Theory and Methods 37(2) (2008), 294-306. [8] E. Giovannucci, E. B. Rimm et al., Intake of fat, meat, and fiber in relation to Risk of colon cancer in men, Cancer Research 54 (1994), 2390-2397. [9] A. Jemal, F. Bray, M. M. Center et al., Global cancer statistics, CA: A Cancer Journal for Clinicians 61 (2011), 69-90. [10] R. Sh. Lipster and A. N. Shiryayev, A functional central limit theorem for semimartingales, Theor. Probab. Appl. 25(4) (1980), 667-688. [11] J. Marron and W. Padgett, Asymptotically optimal bandwidth selection for kernel density estimators from randomly right-censored samples, The Annals of Statistics 15 (1987), 1520-1535. [12] Prashant Mathur et al., Cancer Statistics, 2020: Report From National Cancer Registry Programme, India, JCO Global Oncology 6 (2020), 1063-1075. [13] W. Nelson, Theory and application of hazard plotting for censored failure data, Technometrics 14 (1972), 945-965. [14] Perin N. Notani, Global variation in cancer incidence and mortality, Current Science 81(5) (2001), 465-474. [15] D. M. Parkin, F. Bray et al., Estimating the world cancer burden: GLOBOCAN 2000, Int. J. Cancer 94 (2001), 153-156. [16] Prakash N. Patil and Andrew T. A. Wood, Counting process intensity estimation by orthogonal wavelet methods, Bernoulli Society for Mathematical Statistics and Probability 10 (2004), 1-24. [17] H. Ramlau-Hansen, Smoothing counting process intensities by means of kernel functions, The Annals of Statistics 11 (1983), 453-466. [18] B. P. Rao, Nonparametric Functional Estimation, Academic Press, 1983. [19] M. Rosenblatt et al., Remarks on some nonparametric estimates of a density function, The Annals of Mathematical Statistics 27(3) (1956), 832-837. [20] W. Rudin, Principles of Mathematical Analysis, Vol. 3, McGraw-Hill, New York, 1964. [21] A. N. Shiryayev, Martingales: recent developments, results and applications, The International Statistical Review / Revue Internationale De Statistique 49(3) (1981), 199-233. [22] B. W. Silverman, Density estimation for statistics and data analysis, Monographs on Statistics and Applied Probability, Chapman & Hall, London, 1986. [23] G. R. Terrell and D. W. Scott, Variable kernel density estimation, The Annals of Statistics 20 (1992), 1236-1265. [24] C. MacArthur and A. Smith, Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer, J. Epidemiol Community Health 38(2) (1984), 122-126. [25] R. Nauta, D. M. Stablein and E. D. Holyoke, Survival of patients with stage B2 colon carcinoma, The Gastrointestinal Tumor Study Group experience, Arch Surg. 124 (1989), 180-182. [26] T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, C. Topham, M. Zaninelli, P. Clingan, J. Bridgewater, I. Tabah-Fisch and A. de Gramont, Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) investigators, Oxaliplatin, fluorouracil, and Leucovorin as adjuvant treatment for colon cancer, N. Engl. J. Med. 350 (2004), 2343-2351. [27] J. A. Laurie, C. G. Moertel, T. R. Fleming, H. S. Wieand, J. E. Leigh, J. Rubin, G. W. McCormack, J. B. Gerstner, J. E. Krook and J. Malliard, Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: The North Central Cancer Treatment Group and the Mayo Clinic, J. Clinical Oncology 7 (1989), 1447-1456.
|